Theratechnologies Inc
TSX:TH

Watchlist Manager
Theratechnologies Inc Logo
Theratechnologies Inc
TSX:TH
Watchlist
Price: 4.47 CAD -4.89% Market Closed
Market Cap: 205.5m CAD

Relative Value

The Relative Value of one TH stock under the Base Case scenario is hidden CAD. Compared to the current market price of 4.47 CAD, Theratechnologies Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

TH Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
87
Median 3Y
1
Median 5Y
1.7
Industry
7.9
Forward
1.8
vs History
vs Industry
Median 3Y
-8.1
Median 5Y
-16.1
Industry
24
Forward
-44.8
vs History
6
vs Industry
6
Median 3Y
-6.2
Median 5Y
-23.7
Industry
21.6
vs History
vs Industry
Median 3Y
-3.2
Median 5Y
-6.3
Industry
23.7
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-2.8
Industry
3.4
vs History
42
vs Industry
73
Median 3Y
1.1
Median 5Y
2.1
Industry
8.3
Forward
2.1
vs History
42
vs Industry
73
Median 3Y
1.5
Median 5Y
2.7
Industry
10.3
vs History
1
vs Industry
12
Median 3Y
4.5
Median 5Y
-6.4
Industry
6.7
Forward
14.5
vs History
1
vs Industry
10
Median 3Y
5.9
Median 5Y
-4.4
Industry
7.2
Forward
57.7
vs History
6
vs Industry
4
Median 3Y
-6.3
Median 5Y
-31
Industry
8.2
vs History
vs Industry
1
Median 3Y
-11.5
Median 5Y
-49.3
Industry
6.7
vs History
49
vs Industry
28
Median 3Y
8.6
Median 5Y
9.7
Industry
5.7

Multiples Across Competitors

TH Competitors Multiples
Theratechnologies Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Theratechnologies Inc
TSX:TH
205.5m CAD 1.8 -16.2 17.1 21.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 071 784.8 -161 938.1 -196 644.6 -194 400.6
US
Abbvie Inc
NYSE:ABBV
394.9B USD 6.6 168.2 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
173.1B USD 4.8 24.7 17.9 17.9
US
Gilead Sciences Inc
NASDAQ:GILD
149.9B USD 5.2 18.5 12.4 12.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.9B USD 9.5 30.5 22.3 23.3
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.7 -527.6 -574.5 -559.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
74.4B USD 5.2 16.3 15.4 17.5
AU
CSL Ltd
ASX:CSL
89.8B AUD 3.8 19.9 13.3 16.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
56.9B USD 17.7 1 306.2 172 208.6
NL
argenx SE
XBRU:ARGX
47.9B EUR 15.5 36.4 63.1 64.9
P/E Multiple
Earnings Growth PEG
CA
Theratechnologies Inc
TSX:TH
Average P/E: 202.6
Negative Multiple: -16.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 938.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
168.2
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.7
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.5
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.5
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.3
9%
1.8
AU
CSL Ltd
ASX:CSL
19.9
11%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 306.2
N/A N/A
NL
argenx SE
XBRU:ARGX
36.4
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Theratechnologies Inc
TSX:TH
Average EV/EBITDA: 38.9
17.1
47%
0.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 644.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.9
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
7%
1.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.3
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.5 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.4
11%
1.4
AU
CSL Ltd
ASX:CSL
13.3
8%
1.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
172
N/A N/A
NL
argenx SE
XBRU:ARGX
63.1
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Theratechnologies Inc
TSX:TH
Average EV/EBIT: 45
21.1
37%
0.6
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 400.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.9
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.4
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.3
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.2 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
13%
1.3
AU
CSL Ltd
ASX:CSL
16.6
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
208.6
N/A N/A
NL
argenx SE
XBRU:ARGX
64.9
N/A N/A